Merck KGaA (OTCMKTS:MKKGY) Reaches New 12-Month Low – What’s Next?

Shares of Merck KGaA (OTCMKTS:MKKGYGet Free Report) hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $28.82 and last traded at $28.88, with a volume of 139018 shares trading hands. The stock had previously closed at $29.22.

Wall Street Analysts Forecast Growth

Separately, The Goldman Sachs Group assumed coverage on Merck KGaA in a research note on Thursday, September 19th. They set a “buy” rating on the stock.

Get Our Latest Research Report on Merck KGaA

Merck KGaA Stock Performance

The stock has a 50 day moving average of $31.53 and a 200 day moving average of $34.23. The company has a quick ratio of 0.91, a current ratio of 1.33 and a debt-to-equity ratio of 0.28. The firm has a market cap of $18.56 billion, a price-to-earnings ratio of 17.73, a P/E/G ratio of 2.37 and a beta of 0.93.

About Merck KGaA

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Featured Articles

Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.